Ascenta Capital (investor - Venture Capital)

See something wrong or missing? Let us know

Offices:New York

Ascenta Capital is a New York-based $325 million venture fund focused on multi-medicine, development-stage biotechnology

Average round investment:361.28M USD

Average number per year:1.0

Distribution: 2025 (1)

Portfolio companies: Germany

Tubulis

Mostly invests in: Germany

Germany (1) Biotech (1)

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.